Programme
Chairman: Professor Richard Ceska, MD, PhD, FACP, FEFIM (CZ)
June 12th, 2019
| Time | Event | Host |
|---|---|---|
| 19:00 | Speakers dinner |
June 13th, 2019
| Time | Lecture | Speaker |
|---|---|---|
| 08:30 | Opening Ceremony, Introduction | Prof. R. Češka (CZ) |
| Block I. Atherosclerosis | ||
| 9:00 | The impact of atherosclerosis on cardivascular disease | R. Santos (BR) |
| 9:30 | EUROASPIRE: How good are we in reaching lifestyle and risk factors targets in Europe? | K. Kotseva (GB) |
| 10:00 | Familial hypercholesterolaemia and other sever hypercholesterolemias | A. Gallo (FR) |
| 10:30 | Discussion | |
| 10:45 | Break | |
| Block II. Lipids | ||
| 11:00 | Causal connection between LDL cholesterol and CV disease | R. Češka (CZ) |
| 11:30 | Combo therapy of HLP/DLP. The role of ezetimibe | A. Zambon (IT) |
| 12:00 | Clinical use of PCSK9 inhibitors | G. Latkovskis (LAT) |
| 12:30 | Discussion | |
| 13:00 | Lunch | |
| Block III. Hypertension | ||
| 13:30 | The new “2018 European Society of Cardiology (ESC) and European Society of Hypertension (ESH)Guidelines for the management of arterial hypertension |
J. Widimský (CZ) |
| 14:00 | Compliance and fixed-dose combinations in management of hypertension |
M. Vrablík (CZ) |
| 14:30 | Antihypertensive selection | K. Narkiewicz (PL) |
| 15:00 | Discussion | |
| 15:15 | Break | |
| Block IV. Varia | ||
| 15:30 | Diabetes as a risk factor for CVD | J. Škrha (CZ) |
| 16:00 | Lifestyle & Cardiovascular Risk | D. Gaita (RO) |
| 16:30 | The two faces of statin therapy | P. Lansberg (NL) |
| 17:00 | Case reports- interactive session | R. Češka (CZ) |
| 18:00 | Closing Remarks | R. Češka (CZ) |
June 14th, 2019
| Time | Lecture | Speaker |
|---|---|---|
| Block V. Emergencies and Complex Problems in Cardiology | ||
| 9:00 | Emergencies in ambulatory care | A. Postadgijan (BG) |
| 9:30 | Early ASCVD. From Genes to management. | K. Trušinskis (LV) |
| 10:00 | Post-MI patients treatment | J. Murín (SK) |
| 10:30 | Obesity - The task for cardiometabolism in 21-st Century | D. Dicker (IL) |
| 10:45 | Break | |
| Block VI.Generics | ||
| 11:00 | Generics : How They Work and Why They Are Important | J. Skoupá (CZ) |
| 11:30 | Pharmacoeconomics of cardiovascular disease treatment | T. Doležal (CZ) |
| 12:00 | Round table discussion.Cardiovascular diseases in 21st century | All |
| Closing remarks | R. Češka (CZ) | |
| 13:00 | Lunch | |
| 13:30 | Workshop Complex approach to patient with CV disease |
R. Češka (CZ), T. Altschmiedova (CZ) |
| 15:00 | Closing remarks | R. Češka (CZ) |
| 15:30 | Closing ceremony |
Venue is supported by Czech Society of Internal Medicine and was accredited by EACCME.